[Correspondence] Low-dose CT for lung cancer screening

Even though we three are citizens of the European Union (EU) and the USA, physicians, and authors of multiple guidelines and evidence reviews concerning lung cancer screening,1 –5 we don't presume to speak on behalf of our countries. This trait distinguishes us from Oudkerk and colleagues who called their Policy Review the European position statement on lung cancer screening,6 and, in the abstract, “this European Union (EU) position statement”. Readers of The Lancet Oncology may be unaware that the Policy Review by Oudkerk and colleagues does not in fact reflect any position of either “Europe” or “the EU”, or of any country.

Source: The Lancet Oncology - March 1, 2018 Category: Cancer & Oncology Authors: Peter B Bach, Otis W Brawley, Gerard A Silvestri Tags: Correspondence Source Type: research